drugset / Trial / NCT05408221
the Efficacy and Safety of Rulonilimab in Combination With Lenvatinib in Hepatocellular Carcinoma
RandomizedParallel-groupQuadruple-blindTreatment
Summary
There are two studies included in this protocol. One is an open-label Phase Ⅱ study . The other is a multi-center, double-blind, randomized, phase III study .
Timeline
- Start
- 2022-11-11
- Primary completion
- 2025-08-01
- Completion
- 2026-08-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | F520 | Monoclonal antibody | — | Intravenous |
| Background | Lenvatinib | Small molecule | — | Oral |